Connect with us

Health

FDA advisers debate standards on a coronavirus vaccine for young children – The Washington Post

Executives from Pfizer and Moderna have said that data showing whether their vaccines are effective in younger children are expected…

Published

on

Article feature image
ADVERTISEMENT

The discussion was not centered on a particular vaccine, and it unfolded as Pfizer-BioNTech and Moderna conduct trials of their vaccines in children.
The Pfizer-BioNTech vaccine is already authorized for adolescents as young as 12, and Moderna announced…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Don’t Count on Needing a Covid Booster Shot, WHO Scientist Says – Bloomberg
Article feature image
CDC launches multistate investigation after imported rescue dog tests positive for rabies variant twice eradicated in U.S. – The Washington Post
Article feature image
What’s Set to Be ‘Biggest-Selling Medicine Ever’ Had Bumpy Start – Newser